The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma

Hiroaki Kanzaki(Chiba University), Naoya Kato(Chiba University)
Scientific Reports
March 5, 2021
Cited by 39


Related Papers